Literature DB >> 9501899

Treatment algorithm use to optimize management of symptomatic patients with a history of mania.

T Suppes1, A J Rush, H C Kraemer, A Webb.   

Abstract

BACKGROUND: While monotherapy has significant limitations in bipolar disorder, few published data addressing alternatives exist. Treatment algorithms have been proposed, but none have undergone empirical evaluation. This study provides a systematic prospective, open evaluation of the effectiveness and tolerability of a treatment algorithm for patients with histories of mania.
METHOD: Twenty-eight symptomatic outpatients from a public mental health facility who were diagnosed as having either bipolar I or schizoaffective illness, bipolar type, entered the study. Minimum blood levels of lithium and divalproex sodium were defined. Medications were pushed to predetermined levels (as tolerated) before proceeding to the next algorithm step. Clinical symptoms were assessed monthly using the Brief Psychiatric Rating Scale (BPRS, 27 item) and Clinical Global Impressions scale.
RESULTS: Pretreatment and posttreatment clinical symptoms were compared. Over 50% of patients attained 30% improvement from baseline BPRS after 4 months. Thirty-six percent of patients (N = 10) became mood stable, 46% (N = 13) remained mood unstable, and 18% (N = 5) dropped out before completing the algorithm. Although patients who finished the algorithm were taking more medication, either dosage and/or drugs, somatic complaints did not increase.
CONCLUSION: The potential benefit of a defined treatment algorithm was demonstrated for these complex and persistently ill patients. Despite long treatment histories, patients improved with more frequent visits and addition of medication(s). A randomized controlled trial comparing a similar treatment algorithm with treatment-as-usual is warranted.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9501899     DOI: 10.4088/jcp.v59n0208

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

1.  Association between therapeutic alliance, care satisfaction, and pharmacological adherence in bipolar disorder.

Authors:  Louisa G Sylvia; Aleena Hay; Michael J Ostacher; David J Miklowitz; Andrew A Nierenberg; Michael E Thase; Gary S Sachs; Thilo Deckersbach; Roy H Perlis
Journal:  J Clin Psychopharmacol       Date:  2013-06       Impact factor: 3.153

2.  Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder (Bipolar CHOICE): a pragmatic trial of complex treatment for a complex disorder.

Authors:  Andrew A Nierenberg; Louisa G Sylvia; Andrew C Leon; Noreen A Reilly-Harrington; Leah W Shesler; Susan L McElroy; Edward S Friedman; Michael E Thase; Richard C Shelton; Charles L Bowden; Mauricio Tohen; Vivek Singh; Thilo Deckersbach; Terence A Ketter; James H Kocsis; Melvin G McInnis; David Schoenfeld; William V Bobo; Joseph R Calabrese
Journal:  Clin Trials       Date:  2013-12-17       Impact factor: 2.486

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.